News
Dealbreaker on MSN4h
Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona PharmaVerona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive ...
The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.
Merck to acquire respiratory drug maker, Verona Pharma for $10 billion: Rahway, New Jersey Thursday, July 10, 2025, 09:00 Hrs [IST] Merck, known as MSD outside of the United State ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback